Overview +

Limited Cutaneous Systemic Sclerosis Plasma

Plasma samples from donors diagnosed with limited cutaneous systemic sclerosis (lcSSc) are collected and processed under rigorous standards. These samples support research into skin-limited fibrosis with vascular complications, offering insights into disease mechanisms, biomarker discovery, and therapeutic development.

Product Features

  • Plasma isolated from clinically confirmed lcSSc donors
  • Rigorous donor screening and sample quality checks
  • Suitable for downstream applications such as flow cytometry, RNA-seq, ELISA, and qPCR

Donor Metadata

  • Age, sex, race, medication, diagnosis method, disease severity/stage
  • Optional: comorbidities, lab values, and clinical history

Applications

  • Immunophenotyping
  • Transcriptomics & proteomics
  • Biomarker validation
  • Therapeutic development and screening

Quality and Compliance

  • IRB-approved protocols
  • Informed donor consent
  • Standardized collection and processing SOPs

Ordering & Shipping

Samples are available in both standard and custom volumes to meet your research needs.

International Orders: For international shipments or country-specific documentation requirements, please contact us at [email protected] to ensure compliance with your local regulations.

Protocols and Documentation +

Document Type Technical Document
PDF > Plasma Isolation

Publications +

Plasma Publications

Data and Testing +

Data and Testing with Every Sample

  • Donor demographics
  • Donor-reported allergies
  • Donor-reported infectious disease history

Compliance & Quality Assured

For quality and compliance related information, please visit Sanguine quality and compliance page.

For privacy related information, please visit Sanguine privacy policy page.